| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |